Amylyx Pharmaceuticals, Inc. (AMLX)
15.22
-0.84
(-5.26%)
USD |
NASDAQ |
May 07, 16:00
15.50
+0.28
(+1.87%)
After-Hours: 20:00
Amylyx Pharmaceuticals SG&A Expense (TTM) : 62.89M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Disc Medicine, Inc. | 53.20M |
| Cytokinetics, Inc. | 226.90M |
| Ionis Pharmaceuticals, Inc. | 467.79M |
| MediciNova, Inc. | 6.159M |
| Scholar Rock Holding Corp. | 176.20M |